The real face of eczema in Europe

A new study found that the chronic and relapsing nature of atopic eczema can impact greatly on patient well-being and quality of life. [Anut21ng Photo/Shutterstock]

Atopic eczema has a long time been perceived as a superficial, trivial skin disease. However, a new study found that the chronic and relapsing nature of atopic eczema can impact greatly on patient well-being and quality of life.

Atopic eczema is one of the most common non-communicable inflammatory skin diseases, affecting 1-3% of adults in the EU who suffer from chronic or relapsing itching. For almost 10% of patients with atopic eczema, the condition is severe.

Subscribe to our newsletters

Subscribe

Want to know what's going on in the EU Capitals daily? Subscribe now to our new 9am newsletter.